Literature DB >> 29651118

Myositis: Are autoantibodies pathogenic in necrotizing myopathy?

Marinos C Dalakas1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29651118     DOI： 10.1038/nrrheum.2018.54

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

Review 1.  Inflammatory muscle diseases.

Authors:  Marinos C Dalakas
Journal:  N Engl J Med       Date:  2015-04-30       Impact factor: 91.245

Review 2.  Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors:  Pari Basharat; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

3.  Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.

Authors:  Andrew L Mammen; Tae Chung; Lisa Christopher-Stine; Paul Rosen; Antony Rosen; Kimberly R Doering; Livia A Casciola-Rosen
Journal:  Arthritis Rheum       Date:  2011-03

4.  Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.

Authors:  S Spuler; A G Engel
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

5.  Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.

Authors:  Louiza Arouche-Delaperche; Yves Allenbach; Damien Amelin; Corinna Preusse; Vincent Mouly; Wladimir Mauhin; Gaelle Dzangue Tchoupou; Laurent Drouot; Olivier Boyer; Werner Stenzel; Gillian Butler-Browne; Olivier Benveniste
Journal:  Ann Neurol       Date:  2017-04       Impact factor: 10.422

6.  Expression of immunoreactive major histocompatibility complex products in human skeletal muscles.

Authors:  G Karpati; Y Pouliot; S Carpenter
Journal:  Ann Neurol       Date:  1988-01       Impact factor: 10.422

7.  Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.

Authors:  Yurika Watanabe; Akinori Uruha; Shigeaki Suzuki; Jin Nakahara; Kohei Hamanaka; Kazuko Takayama; Norihiro Suzuki; Ichizo Nishino
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-05-04       Impact factor: 10.154

8.  Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients.

Authors:  Lu Wang; Linlin Liu; Hongjun Hao; Feng Gao; Xiao Liu; Zhaoxia Wang; Wei Zhang; He Lv; Yun Yuan
Journal:  Neuromuscul Disord       Date:  2014-01-13       Impact factor: 4.296

9.  Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.

Authors:  Yves Allenbach; Louiza Arouche-Delaperche; Corinna Preusse; Helena Radbruch; Gillian Butler-Browne; Nicolas Champtiaux; Kuberaka Mariampillai; Aude Rigolet; Peter Hufnagl; Norman Zerbe; Damien Amelin; Thierry Maisonobe; Sarah Louis-Leonard; Charles Duyckaerts; Bruno Eymard; Hans-Hilmar Goebel; Cecile Bergua; Laurent Drouot; Olivier Boyer; Olivier Benveniste; Werner Stenzel
Journal:  Neurology       Date:  2018-01-12       Impact factor: 9.910

10.  Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers.

Authors:  A G Engel; G Biesecker
Journal:  Ann Neurol       Date:  1982-09       Impact factor: 10.422
  10 in total
  8 in total

1.  Anti-HMGCR myopathy presenting with acute systolic heart failure.

Authors:  Mitchell Pitlick; Floranne Ernste
Journal:  BMJ Case Rep       Date:  2019-05-08

2.  Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations.

Authors:  Takashi Kurashige; Tomomi Murao; Naoko Mine; Tomohito Sugiura; Yukiko Inazuka; Kazuya Kuraoka; Tetsuya Takahashi; Hirofumi Maruyama; Tsuyoshi Torii
Journal:  J Neuropathol Exp Neurol       Date:  2020-04-01       Impact factor: 3.685

3.  Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications.

Authors:  Marinos C Dalakas
Journal:  Acta Myol       Date:  2020-12-01

Review 4.  Autoimmune Neurogenic Dysphagia.

Authors:  Panos Stathopoulos; Marinos C Dalakas
Journal:  Dysphagia       Date:  2021-07-05       Impact factor: 2.733

Review 5.  Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.

Authors:  Marinos C Dalakas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-06-09

6.  When Should a Patient with Statin-Induced Myopathy Be Re-challenged? A Case of Necrotizing Autoimmune Myopathy.

Authors:  Elena Obreja; Pamela Sequeira; Diana Girnita
Journal:  Case Rep Rheumatol       Date:  2018-10-01

Review 7.  Neurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune system.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2018-09-14       Impact factor: 6.570

Review 8.  Complement in neurological disorders and emerging complement-targeted therapeutics.

Authors:  Marinos C Dalakas; Harry Alexopoulos; Peter J Spaeth
Journal:  Nat Rev Neurol       Date:  2020-10-01       Impact factor: 42.937
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.